XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders’ Equity | 6 Months Ended
--- | ---
Jun. 30, 2024
Stockholders’ Equity [Abstract] |
STOCKHOLDERS' EQUITY | NOTE 9 – STOCKHOLDERS’ EQUITY Common Stock As of June 30, 2024 and December 31, 2023, the Company had 300,000,000 shares of Common Stock authorized for issuance, of which 66,550,712 and 61,940,878 shares of our Common Stock were issued and outstanding, respectively. Preferred Stock As of June 30, 2024 and December 31, 2023, the Company had 10,000,000 shares of preferred stock, par value $0.0001, authorized, of which 5,000,000 shares are designated as Series A Convertible Preferred Stock (“Series A Preferred”) and 5,000,000 shares are non-designated (“blank check,” together with the Series A Preferred, the “Preferred Shares”) shares. As of June 30, 2024 and December 31, 2023, the Company had no preferred stock outstanding. Form S-3 On January 29, 2021, the Company filed a shelf Registration Statement on Form S-3 for up to $150,000,000 with the SEC (the “Prior Form S-3”) for shares of its Common Stock; shares of its preferred stock, which the Company may issue in one or more series or classes; debt securities, which the company may issue in one or more series; warrants to purchase its Common Stock, preferred stock or debt securities; and units. The Prior Form S-3 was declared effective by the SEC on February 5, 2021. In accordance with SEC rules, the Prior Form S-3 expired on February 5, 2024, the three-year anniversary of the date on which it was declared effective. On February 2, 2024, the Company initially filed with the SEC a new shelf Registration Statement on Form S-3 for up to $175,000,000, which represents $150,000,000 under the Prior Form S-3 and an additional $25,000,000 (the “New Form S-3”), for shares of its Common Stock; shares of its preferred stock, which the Company may issue in one or more series or classes; debt securities, which the company may issue in one or more series; warrants to purchase its Common Stock, preferred stock or debt securities; and units. The New Form S-3 was declared effective by the SEC on February 15, 2024. Stock Issued for Convertible Debt During the six months ended June 30, 2024, the Company issued 340,855 shares of its Common Stock to the lenders in lieu of cash payments for $187 of outstanding interest and $250,000 of outstanding principal on the 2022 Convertible Exchange Notes. During the six months ended June 30, 2023, the Company issued 5,446,692 shares of its Common Stock to the lenders in lieu of cash payments for $164,054 of outstanding interest and $5,585,946 of outstanding principal on the 2022 Convertible Exchange Notes (See Note 8 – Long-term Notes Payable for further details). Sale of Common Stock in Ondas Holdings and Warrants to Purchase Common Stock of OAS On February 26, 2024, the Company entered into a Securities Purchase Agreement (the “Ondas Agreement”) with certain purchasers named therein (the “Ondas Purchasers”) for the purchase and sale of (i) an aggregate of 3,616,071 shares (the “Holdings Shares”) of Common Stock and (ii) warrants to purchase an aggregate of 3,616,071 shares of OAS’ common stock $0.0001 par value per share, at an exercise price of 80% of the lowest price of Common Shares of OAS issued in a subsequent financing of at least $10,000,000 to the Company, and exercisable commencing ninety days following the date of issuance through the fifth anniversary of the date of issuance (the “OAS Warrants,” and together with the Holdings Shares, the “Ondas Offering Securities”), for gross proceeds of $4,050,000 (the “Ondas Offering”). The purchase price paid by the Ondas Purchasers for the Holdings Shares was $1.12 per share. The Company engaged a third-party service provider to carry out an appraisal of the OAS Warrants, who ran a Monte Carlo simulation to determine the fair value of the OAS Warrants as of February 26, 2024, which is $1,561,532. The initial valuation was assigned to the Holdings Shares and the OAS Warrants based on their relative fair values, with the initial valuation of the Holdings Shares being $3,095,263 and OAS Warrants being $954,737. The Ondas Offering was consummated on February 26, 2024. The Holdings Shares were offered and sold, and were issued, pursuant to the Prospectus Supplement, dated February 26, 2024, to the Prospectus included in the New Form S-3. The Company intends to use the net proceeds from the sale of the Ondas Offering Securities for general working capital purposes. The issuance of the OAS Warrants was exempt from registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(2) of such Securities Act and Regulation D promulgated thereunder based upon the representations of each of the Ondas Purchasers that it was an “accredited investor” (as defined under Rule 501 of Regulation D) and that it was purchasing such securities without a present view toward a distribution of the securities. In addition, there was no general advertisement conducted in connection with the sale of the OAS Warrants. See the Current Report on Form 8-K filed with the SEC on February 26, 2024 for further details. Warrants to Purchase Common Stock of the Company We use the Black-Scholes-Merton option model (the “Black-Scholes Model”) to determine the fair value of warrants to purchase Common Stock of the Company. The Black-Scholes Model is an acceptable model in accordance with U.S GAAP. The Black-Scholes Model requires the use of a number of assumptions including volatility of the stock price, the weighted average risk-free interest rate, and the weighted average term of the warrant. The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the warrants. Estimated volatility is a measure of the amount by which our stock price is expected to fluctuate each year during the expected life of the award. Our estimated volatility is an average of the historical volatility of peer entities whose stock prices were publicly available over a period equal to the expected life of the awards. We used the historical volatility of peer entities due to the lack of sufficient historical data of our stock price. On February 26, 2024, the Company issued warrants to purchase 3,015,000 shares of the Company’s Common Stock, at an exercise price of $1.26 per share, and with a relative fair value of $1,471,194, in connection with the sale of redeemable preferred stock in Ondas Networks. See Note 10 – Redeemable Noncontrolling Interest. On June 3, 2024, the Company issued warrants to purchase 662,723 shares of the Company’s Common Stock, at an exercise price of $0.72 per share, and with a fair value of $193,250, in consideration of consulting services for the Company. On June 3, 2024, the Company issued warrants to purchase 15,391 shares of Ondas Networks Common Stock in consideration of consulting services for the Company. The Company engaged a third-party service provider to carry out a valuation of Ondas Networks’ Common Stock to determine its fair value as of May 31, 2024 and has recorded stock-based compensation of $84,992 during the six months ended June 30, 2024 based on the preliminary valuation. The assumptions used in the Black-Scholes Model are set forth in the table below.
|  | Six Months Ended June 30, 2024 |
|  | Ondas Holdings |
Stock price |  |  | $0.72-1.40 |
Risk-free interest rate |  |  | 4.29-4.62% |
Volatility |  |  | 61.86-64.45% |
Expected life in years |  |  | 2.75-5.00 |
Dividend yield |  |  | 0.00% |
A summary of our Warrants activity for the three and six months ended June 30, 2024 and related information follows:
|  | Number of Shares Under Warrant |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |
Balance as of January 1, 2024 |  |  | 12,566,092 |  |  | $ | 2.22 |  |  |  | 4.71 |
Granted |  |  | 3,015,000 |  |  |  | 1.26 |  |  |  |  |
Balance as of March 31, 2024 |  |  | 15,581,092 |  |  | $ | 2.03 |  |  |  | 4.54 |
Granted |  |  | 753,682 |  |  |  | 0.71 |  |  |  |  |
Exercised |  |  | (46,893 | ) |  |  | 0.03 |  |  |  |  |
Cancelled |  |  | (455,834 | ) |  |  | 9.26 |  |  |  |  |
Balance as of June 30, 2024 |  |  | 15,831,998 |  |  | $ | 1.77 |  |  |  | 4.46 |
Stock Options to Purchase Common Stock The Company awards stock options to certain employees, directors, and consultants, which represent the right to purchase common shares on the date of exercise at a stated exercise price. Stock options granted to employees generally vest over a two to four-year period and are contingent on ongoing employment. Compensation expenses related to these awards is recognized straight-line over the applicable vesting period. Stock options granted to consultants are subject to the attainment of pre-established performance conditions. The actual number of shares subject to the award is determined at the end of the performance period and may range from zero to 100% of the target shares granted depending upon the terms of the award. Compensation expenses related to these awards is recognized when the performance conditions are satisfied. A summary of our Option activity for the three and six months ended June 30, 2024 and related information follows:
|  | Number of Shares Under Option |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |
Balance as of January 1, 2024 |  |  | 4,854,507 |  |  | $ | 4.59 |  |  |  | 7.34 |
Exercised |  |  | (4,535 | ) |  |  | 0.49 |  |  |  |  |
Forfeited |  |  | (58,400 | ) |  |  | 3.12 |  |  |  |  |
Canceled |  |  | (272,401 | ) |  |  | 9.76 |  |  |  |  |
Balance as of March 31, 2024 |  |  | 4,519,171 |  |  | $ | 4.30 |  |  |  | 7.30 |
Granted |  |  | 804,500 |  |  |  | 1.07 |  |  |  |  |
Exercised |  |  | (9,660 | ) |  |  | 0.87 |  |  |  |  |
Forfeited |  |  | (43,709 | ) |  |  | 1.74 |  |  |  |  |
Canceled |  |  | (320,895 | ) |  |  | 4.92 |  |  |  |  |
Balance as of June 30, 2024 |  |  | 4,949,407 |  |  | $ | 3.77 |  |  |  | 7.79 |
Vested and Exercisable as of June 30, 2024 |  |  | 2,364,616 |  |  | $ | 5.47 |  |  |  | 6.48 |
As of June 30, 2024, total unrecognized compensation expense related to non-vested stock options was $1,743,788 which is expected to be recognized over a weighted average period of 2.88 years. Total stock-based compensation expense for stock options for the three and six months ended June 30, 2024 and 2023 is as follows:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
General and administrative |  | $ | 218,635 |  |  | $ | 88,271 |  |  | $ | 290,218 |  |  | $ | 207,470 |
Sales and marketing |  |  | 80,412 |  |  |  | 128,840 |  |  |  | 151,966 |  |  |  | 258,587 |
Research and development |  |  | 37,089 |  |  |  | 78,311 |  |  |  | 77,405 |  |  |  | 131,602 |
Cost of goods sold |  |  | 19,108 |  |  |  | 16,330 |  |  |  | 37,048 |  |  |  | 19,022 |
Total stock-based expense related to options |  | $ | 355,244 |  |  | $ | 311,752 |  |  | $ | 556,637 |  |  | $ | 616,681 |
Restricted Stock Units The Company recognizes restricted stock unit expense over the period of vesting or period that services will be provided. Compensation associated with shares of Common Stock issued or to be issued to consultants and other non-employees is recognized over the expected service period beginning on the measurement date, which is generally the time the Company and the service provider enter into a commitment whereby the Company agrees to grant shares in exchange for the services to be provided. The following is a summary of restricted stock unit activity for the three and six months ended June 30, 2024:
|  | RSUs |  |  | Weighted Average Grant Date Fair Value |  |  | Weighted Average Vesting Period (Years) |
Unvested balance as of January 1, 2024 |  |  | 554,466 |  |  | $ | 1.14 |  |  |  | 0.66 |
Vested |  |  | (146,419 | ) |  |  | 0.70 |  |  |  |  |
Unvested balance as of March 31, 2024 |  |  | 408,047 |  |  | $ | 1.30 |  |  |  | 0.48 |
Vested |  |  | (125,375 | ) |  |  | 0.68 |  |  |  |  |
Unvested balance as of June 30, 2024 |  |  | 282,672 |  |  | $ | 1.58 |  |  |  | 0.23 |
As of June 30, 2024, the unrecognized compensation expense for RSUs was $49,543. Total stock-based compensation expense for restricted stock units for the three and six months ended June 30, 2024 and 2023 is as follows:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
General and administrative |  | $ | 48,477 |  |  | $ | 855,468 |  |  | $ | 106,634 |  |  | $ | 1,473,307 |
Sales and marketing |  |  | 4,065 |  |  |  | 9,498 |  |  |  | 13,564 |  |  |  | 18,893 |
Research and development |  |  | 211 |  |  |  | 463,151 |  |  |  | 715 |  |  |  | 794,344 |
Total stock-based expense related to restricted stock units |  | $ | 52,753 |  |  | $ | 1,328,117 |  |  | $ | 120,913 |  |  | $ | 2,286,544 |
Equity Incentive Plan In 2018, our stockholders adopted the 2018 Equity Incentive Plan (the “2018 Plan”) pursuant to which 3,333,334 shares of our Common Stock have been reserved for issuance to employees, including officers, directors and consultants. The 2018 Plan is administered by the Board, provided however, that the Board may delegate such administration to the compensation committee of the Board of the Company (the “Compensation Committee”). Subject to the provisions of the 2018 Plan, the Board and/or the Compensation Committee has the authority to grant, in its discretion, incentive stock options, or non-statutory options, stock awards or restricted stock purchase offers (“Equity Awards”). As of June 30, 2024, the balance available to be issued under the 2018 Plan was 1,058,403. At the 2021 Annual Meeting of Stockholders of the Company held on November 5, 2021, stockholders of the Company approved, among other matters, the Ondas Holdings Inc. 2021 Stock Incentive Plan (the “2021 Plan”). The Compensation Committee of the Board of Directors of the Company adopted the 2021 Plan on September 30, 2021, subject to stockholder approval. The purpose of the 2021 Plan is to enable the Company to attract, retain, reward, and motivate eligible individuals by providing them with an opportunity to acquire or increase a proprietary interest in the Company and to incentivize them to expend maximum efforts for the growth and success of the Company, so as to strengthen the mutuality of the interests between the eligible individuals and the shareholders of the Company. The 2021 Plan provides for the issuance of awards including stock options, stock appreciation rights, restricted stock, restricted stock units, and performance awards. On October 31, 2023, stockholders of the Company approved an amendment to the 2021 Plan to increase the number of shares of the Company’s Common Stock authorized for issuance under the 2021 Plan from 6,000,000 to 8,000,000 shares. As of June 30, 2024, the balance available to be issued under the 2021 Plan was 3,467,704.

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration